ArticlePloS one2026
Modifications to a vegan artificial honey result in inhibitory activity against Mycobacterium abscessus.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The multidrug resistant Mycobacterium abscessus is an opportunistic pathogen of increasing concern, causing infections of skin and soft tissue as well as pulmonary, it can be life-threatening for immunocompromised individuals. Current treatment strategies are ineffective and new approaches to combat infections are imperative. The antimicrobial potential of Manuka honey has been recently demonstrated to be effective against M. abscessus, but the potential to improve its efficacy as well as reduce demand on a natural resource have not yet been explored. The development of medical honey paves the way for generation of a synthetic honey, but this information is largely hidden behind patents and also not explored from a synergist perspective of combined activity of MGO, H2O2 and defensin-1. Through addition of key enzymes or components and antimicrobial susceptibility testing, we have demonstrated that a vegan honea, containing no bee derived component results in antimicrobial activity against M. abscessus, causing not only growth inhibition but bactericidal activity. Both MGO and H2O2 are demonstrated to be relevant to the killing effect against M. abscessus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.